Key result
A survey of 76 Indian physicians on VTE management found that 63.16% rely on clinical signs for diagnosis, 82.89% prefer duplex ultrasonography, and dabigatran is the preferred treatment.
Why the study?
The study was conducted to understand the management and clinical practicing patterns of venous thromboembolism by physicians in India.
Observational (n=76)
Yes
Answers are grounded in this paper and cite their sources.
This survey highlights current clinical practice patterns for VTE management among Indian physicians, showing a preference for DOACs and clinical examination over standardized risk scores.
Background: We conducted a physician-based survey to understand the management and clinical practicing patterns of venous thromboembolism (VTE) by physicians in India. Methods: This was an observational, physician-based clinical survey. A set of 22 questions on diagnosis, prophylaxis, duration of treatment, and risk factors of VTE was formulated along with nine patient case-studies. Seventy-six consulting physicians across India responded to the survey questionnaire. An expert panel comprising vascular surgeon, cardiac surgeon, and senior physicians provided recommendations on the recorded survey responses. Results: About 63.16% of physicians considered clinical examination of VTE based on signs and symptoms, whereas 23.68% used deep-vein thrombosis (DVT) scores (Wells score) to assess patients' risk. Recent surgery was considered a risk factor for developing DVT or pulmonary embolism by 86.84% of physicians; 82.89% preferred performing duplex ultrasonography test, and on positive results, treated patients for DVT. Dabigatran was the preferred choice of treatment by the participants. VTE prophylaxis with oral anticoagulants was considered by 80.3% of physicians during major orthopedic surgery. Direct oral anticoagulant (DOAC) with bridging therapy was preferred by 44.74% of physicians and 77.63% felt that DOACs will lead to a better quality of life for VTE patients. For patients with permanent risk factors of DVT, 76.32% of physicians preferred the indefinite duration of anticoagulation therapy. Conclusions: VTE remains a growing area of concern that needs to be managed in line with the clinical guidelines. These insights may aid in developing strategies for diagnostic accuracy and treatment of DVT.
No takes yet. Share an insight, caveat, or question.
Bedi et al. (2021) conducted an observational in Venous thromboembolism (n=76). Clinical practice patterns survey was evaluated on Survey responses on VTE diagnosis, prophylaxis, and treatment. A survey of 76 Indian physicians on VTE management found that 63.16% rely on clinical signs for diagnosis, 82.89% prefer duplex ultrasonography, and dabigatran is the preferred treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: